What Is Recombinant Interferon?

Recombinant human interferon is a medicine suitable for the treatment of malignant tumors, subacute severe hepatitis, liver fibrosis (early liver cirrhosis), infection and injury diseases, myelodysplastic syndrome, viral diseases, systemic crust Disease, atopic dermatitis, rheumatoid arthritis and other symptoms.

Recombinant human interferon

Recombinant human interferon is a medicine suitable for treatment
It is used to treat vaginal viral infections
The most common is fever, most of which are low fever (below 38 ° C) and subside for several hours. Few patients have adverse reactions such as fatigue, discomfort, headache, myalgia, joint pain, loss of appetite, and nausea. Common laboratory abnormalities are transient granulocyte and thrombocytopenia. If serious side effects occur, reduce the dose or discontinue the drug and give symptomatic treatment.
Recombinant human interferon 2a
Recombinant human interferon 2a has a broad-spectrum antiviral effect, and its antiviral mechanism mainly binds interferon receptors on the surface of target cells through interferon to induce 2-5 (A) synthetase, protein kinase PKR, and MX proteins in target cells. A variety of antiviral proteins are achieved by preventing the synthesis of viral proteins and inhibiting the replication and transcription of viral nucleic acids. Interferon also has multiple immunoregulatory effects, which can increase the phagocytic activity of macrophages and enhance the specific cytotoxicity of lymphocytes to target cells, and promote and maintain the body's immune surveillance, immune protection and immune stabilization functions. Toxicology: 1.
Recombinant human interferon is used with other drugs at the same time, and has no effect on the efficacy.
Very few patients have mild waist and abdomen pain after the first application, occasional transient low fever, vulvar and vaginal discomfort, and can disappear on their own without affecting treatment.
Recombinant human interferon kidney transplantation is contraindicated in children and pregnant women.
60,000 IU / capsule
6 pieces / box
Put the suppository in the vaginal cavity, one at a time, every other day, before bedtime, 6-10 times for a course of treatment or as directed by your doctor.
Use under the guidance of a physician with clinical experience. Each bottle is dissolved with 1ml of sterile injection water, injected intramuscularly or subcutaneously. The dosage and course of treatment are recommended as follows:
Hairy cell leukemia: 40-60 g, injected once a day, continuous medication for more than six months, can be appropriately adjusted according to the condition, and can be changed to another injection every other day after remission.
Chronic Hepatitis B and Hepatitis C: 40 g (20-60 g), injected once a day, or changed to 3 times a week after 4 weeks of treatment, continuous treatment for 3 months or longer.
Recombinant human interferon should be protected from light, dry and stored at 2-8 degrees. Valid for 18 months.
It is forbidden to take a bath or sex during medication, and to stop medication during menstruation. If the ambient temperature is too high during use and the suppository body becomes soft (without affecting the curative effect), please place it in a refrigerator at 4 or cold water for 3 to 5 minutes before tearing the plastic out for use.

IN OTHER LANGUAGES

Was this article helpful? Thanks for the feedback Thanks for the feedback

How can we help? How can we help?